Pain Relief and Functional Outcome After Partial Denervation of the Wrist
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03378362 |
|
Recruitment Status :
Recruiting
First Posted : December 19, 2017
Last Update Posted : March 3, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Wrist Arthritis | Procedure: Partial denervation of the wrist joint | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 60 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | A Prospective Study on Pain Relief and Functional Outcome After Partial Denervation of the Wrist |
| Actual Study Start Date : | December 31, 2017 |
| Estimated Primary Completion Date : | August 31, 2021 |
| Estimated Study Completion Date : | August 31, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Partial denervation of the wrist joint
Patients will be operated with a partial denervation of the wrist through a single dorsal approach.
|
Procedure: Partial denervation of the wrist joint
Partial denervation of the wrist (posterior and anterior interosseous neurectomy) through a single dorsal approach. |
- Change in Disability of the Arm, Shoulder and Hand score (DASH) [ Time Frame: peroperatively, 3, 6 and 12 months postoperatively ]questionnaire
- Change in Patient Related Wrist Evaluation (PRWE) [ Time Frame: peroperatively, 3, 6 and 12 months postoperatively ]questionnaire
- Change in EQ5D [ Time Frame: peroperatively, 3, 6 and 12 months postoperatively ]questionnaire
- Change in Hospital Anxiety and Depression Scale (HADS) [ Time Frame: peroperatively, 3, 6 and 12 months postoperatively ]questionnaire. Determines the levels of anxiety and depression. 14 item scale that generates ordinal data. Seven items relate to anxiety and seven to depression. Each item is scored from 0-3, which means that a person can score between 0-21 for either depression or anxiety. A score of 11 or above on either scale in considered to repressent depression or anxiety.
- Change in range of motion, grip strength [ Time Frame: peroperatively, 3, 6 and 12 months postoperatively ]objective physical function
- Change in Sence Of Coherence -13 (SOC13) [ Time Frame: peroperatively, 3, 6 and 12 months postoperatively ]Questionnaire
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion criteria
- Chronic wrist pain (≥6 months) due to posttraumatic arthritis after distal radius fracture or SLAC/SNAC arthritis or arthritis due to Mb Preiser/Mb Kienböck where surgical unloading of the bone isn't possible.
- Pain is refractory to nonsurgical management such as bracing, corticosteroid injection, oral analgesics, NSAIDs, physiotherapy.
Exclusion criteria
- Rheumatoid or other inflammatory arthritis.
- Previous wrist surgery with simultaneous PIN/AIN neurectomy.
- Simultaneous arthritis or symptomatic instability of the distal radio ulnar (DRU) joint on the ipsilateral side.
- Inability to co-operate with the follow-up protocol (language difficulties, severe psychiatric disorder, cognitive impairment, drug addiction).
- Patient's wish for a definite procedure.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03378362
| Contact: Elin Sward, MD | +46704820372 | elin.sward@sll.se | |
| Contact: Maria Wilcke, MD, PhD |
| Sweden | |
| Handkirurgiska kliniken Södersjukhuset | Recruiting |
| Stockholm, Sweden, 11883 | |
| Contact: Elin M Swärd, Md +46704820372 Elin.sward@sll.se | |
| Contact: Maria Wilcke +46708294613 Maria.wilcke@sll.se | |
| Study Director: | Maria Wilcke, MD, PhD | Karolinska Institutet |
| Responsible Party: | Elin Swärd, MD, Principal Investigator, Karolinska Institutet |
| ClinicalTrials.gov Identifier: | NCT03378362 |
| Other Study ID Numbers: |
Karolinska Institute |
| First Posted: | December 19, 2017 Key Record Dates |
| Last Update Posted: | March 3, 2021 |
| Last Verified: | March 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Arthritis Joint Diseases Musculoskeletal Diseases |

